Fight CRC Hits NYC — Summertime Planning Updates

One Million Strong is a MOVEMENT uniting those impacted by colorectal cancer. And last week – Fight Colorectal Cancer was on the MOVE. Check out what was happening amongst some of our team members as they hit New York City! Planning One Million Strong: NYC 2014 Anjee Davis, VP of Programs, and Emily White, Program Coordinator,…  Read More

Hausmanns Raise Awareness, Funds through Softball and Horseshoes

Sometimes, love is seen through a Lady-and-the-Tramp kind of story – Italian dinners lead to sharing spaghetti and gazing into one another’s eyes. At Fight Colorectal Cancer, we have another kind of love story that gives us warm fuzzies every time we see 2013 Advocates of the Year Eric and Rose Hausmann. But instead of spaghetti…  Read More

Stage II Colon Cancer – Chemo or No Chemo?

A brief in a running series from 2013 ASCO® conference: Prognostic Tests – to use or not use . . .  or rather  … To treat or not to treat? New studies for stage II colon cancer patients contemplating chemotherapy . by: Nancy Roach One of the toughest decisions for patients with stage II colon cancer is…  Read More

Experts Issue Practice-Changing Advice: Stop giving calcium/magnesium for oxaliplatin-caused neuropathy

For patients getting the common FOLFOX chemotherapy for colorectal cancer, many oncologists add intravenous calcium and magnesium, hoping to decrease the neuropathy (nerve damage) associated with oxaliplatin-based drugs. But this week, experts at the 2013 ASCO meeting (American Society of Clinical Oncology), announced strong evidence that the calcium/magnesium does no good in either preventing or decreasing…  Read More

Don't confuse bargain shopping with saving lives!

FIGHT COLORECTAL CANCER RESPONSE TO NEW YORK TIMES ARTICLE (6/03/2013): Fight Colorectal Cancer applauds the New York Times for shedding light on how revenue is generated by medical practices. Importantly however, the crux of the issue is not the use or overuse of colonoscopies and the variance in pricing. Rather, the main problem to be fixed…  Read More

Clinical Conundrum: When, how to treat colorectal cancer in the elderly

Even as scientists plumb deep into cells and molecules to understand cancer, there are many immediate and “real-life” questions that researchers and clinicians are discussing at the 2013 annual ASCO meeting (American Society of Clinical Oncology). One of the biggest puzzles for colorectal cancer is how to best treat the elderly, especially those with stages II…  Read More